PBM (Psyence Biomedical) Dividends per Share : $0.00 (TTM As of Sep. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Dividends per Share?

Psyence Biomedical's dividends per share for the six months ended in Sep. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00. Its Dividend Payout Ratio for the six months ended in Sep. 2023 was 0.00. As of today, Psyence Biomedical's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Psyence Biomedical Dividends per Share Historical Data

The historical data trend for Psyence Biomedical's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Dividends per Share Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Dividends per Share

Psyence Biomedical Semi-Annual Data
	Mar22	Sep22	Mar23	Sep23	Mar24
Dividends per Share	-	-	-	-	-

Competitive Comparison of Psyence Biomedical's Dividends per Share

For the Biotechnology subindustry, Psyence Biomedical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Dividend Yield % falls into.

Psyence Biomedical Dividends per Share Calculation

Dividends paid to per common share.

Psyence Biomedical (NAS:PBM) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Psyence Biomedical's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-8.663
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Psyence Biomedical Dividends per Share Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.